1. Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis

   • Zachary Baldwin
   • Boshen Jiao
   • Beth Devine

   Systematic Review Open access 26 April 2022 Pages: 469 - 481

   

2. Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting

   • Sabine Michelsen Raunbak
   • Anne Sig Sørensen
   • Lars Holger Ehlers

   Original Research Article Open access 05 June 2022 Pages: 483 - 494

   

3. Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway

   • Tron Anders Moger
   • Åsne Holen
   • Solveig Hofvind

   Original Research Article Open access 07 July 2022 Pages: 495 - 507

   

4. Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain

   • Ángel Gil de Miguel
   • José María Eiros Bouza
   • Laura Martin-Gomez

   Original Research Article Open access 07 March 2022 Pages: 509 - 518

   

5. Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada

   • Elisabetta Fenu
   • Vasily Lukyanov
   • Mark Oppe

   Original Research Article Open access 26 April 2022 Pages: 519 - 537

   

6. Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand

   • Chunhuan Lao
   • Mohana Mondal
   • Ross Lawrenson

   Original Research Article Open access 19 February 2022 Pages: 539 - 548

7. Cost-Effectiveness Analysis of Intravascular Targeted Temperature Management after Cardiac Arrest in England

   • Mehdi Javanbakht
   • Atefeh Mashayekhi
   • Mohsen Yaghoubi

   Original Research Article Open access 03 May 2022 Pages: 549 - 562

   

8. Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument

   • Matthew Reaney
   • Veleka Allen
   • Iacopo Olivotto

   Original Research Article Open access 02 June 2022 Pages: 563 - 574

   

9. Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial

   • Matthew Reaney
   • Prithvi Addepalli
   • Jennifer T. Fine

   Original Research Article Open access 20 June 2022 Pages: 575 - 586

10. Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial

    • Anh Dam Tran
    • Angela M. Hong
    • Rachael L. Morton

    Original Research Article Open access 05 May 2022 Pages: 587 - 594

    

11. Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping Algorithms

    • Michela Meregaglia
    • Rosanna Tarricone

    Original Research Article Open access 19 February 2022 Pages: 595 - 603

    

12. Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis

    • Nafsika Afentou
    • Emma Frew
    • the PREDNOS Collaborative Group, NIHR Medicines for Children Research Network Nephrology Clinical Studies Group

    Original Research Article Open access 22 June 2022 Pages: 605 - 617

    

13. Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis

    • Zeki Kocaata
    • Thomas Wilke
    • Hermann Einsele

    Original Research Article Open access 24 June 2022 Pages: 619 - 628

    

14. Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries

    • Anna-Maria Fontrier
    • Erica Visintin
    • Panos Kanavos

    Correction Open access 01 July 2022 Pages: 629 - 629